Stock listing

Teva Pharmaceutical Industries Limited

Selected listing: 0LER · LSIN · USD · GB

Teva Pharmaceutical Industries Limited (LSIN:0LER), Health Technology. Latest release Oct 1, 2026: Samsung Bioepis and Teva Expand Strategic Partnership…

0LER:LSINUSDGBUpdated September 25, 2026

Ticker: LSIN:0LER
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Generic
Exchange: LSIN
Currency: USD

Latest news from Teva Pharmaceutical Industries Limited

Samsung Bioepis and Teva Expand Strategic Partnership to Advance Up to Six Potential Biosimilar Candidates

October 1, 2026

Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab)

September 28, 2026

Teva to Host Conference Call to Discuss Third Quarter 2026 Financial Results on November 3, 2026 at 8 a.m. ET

September 23, 2026

Teva Releases Q3 2026 Aide Memoire

September 23, 2026

Teva Begins Trading Ordinary Shares Directly on the NYSE, Marking a Milestone in its Pivot to Growth Strategy

September 14, 2026

All Teva Pharmaceutical Industries Limited news →

Events

Replays

Teva Pharmaceutical Industries Limited (TEVA) Q2 2026 Earnings Call
Wed, Jul 29, 2026 · 08:00 AM ET
Watch
Teva Pharmaceutical Industries Limited (TEVA) Q1 2026 Earnings Call
Wed, Apr 29, 2026 · 08:00 AM ET
Watch
Teva Pharmaceutical Industries Limited (TEVA) Q4 2025 Earnings Call
Wed, Jan 28, 2026 · 08:00 AM ET
Watch

Research Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited company profile

View the public company page for Teva Pharmaceutical Industries Limited on 6ix.

Teva Pharmaceutical Industries Limited news

Read company news and market updates connected to Teva Pharmaceutical Industries Limited.

Teva Pharmaceutical Industries Limited investor events

Find investor webinars, events, and replay context for Teva Pharmaceutical Industries Limited.